Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Cholesterol, LDL | 13 | 2019 | 499 | 2.08 | Why? |
Anticholesteremic Agents | 10 | 2019 | 186 | 1.78 | Why? |
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2019 | 1510 | 1.75 | Why? |
Physical Endurance | 4 | 2020 | 107 | 1.56 | Why? |
Telomerase | 2 | 2019 | 45 | 1.55 | Why? |
Heart Failure | 12 | 2019 | 6638 | 1.27 | Why? |
Resistance Training | 2 | 2019 | 273 | 1.23 | Why? |
Ventricular Remodeling | 2 | 2019 | 349 | 1.16 | Why? |
Dyslipidemias | 7 | 2019 | 791 | 1.11 | Why? |
Mitral Valve Insufficiency | 2 | 2018 | 302 | 1.06 | Why? |
Lipoproteins, LDL | 3 | 2019 | 115 | 1.04 | Why? |
Hypercholesterolemia | 3 | 2019 | 175 | 1.00 | Why? |
Cardiovascular Diseases | 16 | 2019 | 11497 | 0.95 | Why? |
Hyperlipoproteinemia Type II | 3 | 2018 | 123 | 0.92 | Why? |
Atherosclerosis | 4 | 2017 | 768 | 0.91 | Why? |
Ventricular Function, Left | 4 | 2020 | 1555 | 0.87 | Why? |
Exercise Tolerance | 3 | 2020 | 634 | 0.86 | Why? |
Receptors, Mineralocorticoid | 1 | 2019 | 15 | 0.81 | Why? |
Naphthyridines | 1 | 2019 | 48 | 0.80 | Why? |
Receptors, LDL | 2 | 2018 | 42 | 0.79 | Why? |
Atrial Remodeling | 1 | 2019 | 31 | 0.78 | Why? |
Phosphatidylethanolamine Binding Protein | 1 | 2018 | 2 | 0.78 | Why? |
Cardiovascular Agents | 4 | 2019 | 663 | 0.78 | Why? |
Xanthomatosis | 1 | 2018 | 11 | 0.75 | Why? |
Telomere Homeostasis | 1 | 2019 | 52 | 0.75 | Why? |
Apoptosis | 3 | 2018 | 2335 | 0.75 | Why? |
Lipid Metabolism | 3 | 2017 | 572 | 0.73 | Why? |
Coumaric Acids | 1 | 2017 | 11 | 0.72 | Why? |
Interdisciplinary Studies | 1 | 2018 | 95 | 0.71 | Why? |
Fibroblasts | 3 | 2019 | 839 | 0.71 | Why? |
Palmitic Acid | 1 | 2017 | 28 | 0.71 | Why? |
Adrenergic beta-Antagonists | 2 | 2019 | 465 | 0.70 | Why? |
Mineralocorticoid Receptor Antagonists | 1 | 2019 | 203 | 0.68 | Why? |
AMP-Activated Protein Kinases | 1 | 2017 | 93 | 0.66 | Why? |
Cell-Derived Microparticles | 1 | 2017 | 134 | 0.64 | Why? |
Oryza | 1 | 2017 | 86 | 0.63 | Why? |
Cholesterol, HDL | 4 | 2019 | 439 | 0.63 | Why? |
Running | 1 | 2017 | 153 | 0.59 | Why? |
Coronary Thrombosis | 1 | 2020 | 433 | 0.58 | Why? |
Myocytes, Cardiac | 3 | 2019 | 804 | 0.57 | Why? |
Comprehension | 1 | 2017 | 259 | 0.55 | Why? |
Myocardium | 4 | 2019 | 2323 | 0.55 | Why? |
Medication Adherence | 3 | 2019 | 1270 | 0.55 | Why? |
Coronary Disease | 2 | 2017 | 645 | 0.55 | Why? |
Mitral Valve | 1 | 2018 | 342 | 0.54 | Why? |
Physical Fitness | 1 | 2017 | 334 | 0.54 | Why? |
Cardiac Catheterization | 2 | 2018 | 882 | 0.54 | Why? |
Echocardiography | 5 | 2020 | 3661 | 0.53 | Why? |
Takotsubo Cardiomyopathy | 1 | 2020 | 453 | 0.53 | Why? |
Stroke Volume | 3 | 2019 | 2153 | 0.52 | Why? |
Ventricular Dysfunction, Left | 2 | 2020 | 993 | 0.51 | Why? |
Cardiovascular System | 2 | 2018 | 750 | 0.50 | Why? |
Plaque, Atherosclerotic | 1 | 2017 | 423 | 0.48 | Why? |
Cardiomyopathies | 2 | 2018 | 997 | 0.46 | Why? |
Myalgia | 1 | 2017 | 1015 | 0.46 | Why? |
Heart Valve Prosthesis Implantation | 1 | 2018 | 552 | 0.45 | Why? |
Cognition | 2 | 2017 | 1394 | 0.45 | Why? |
Fibrosis | 4 | 2019 | 800 | 0.45 | Why? |
Oxidative Stress | 4 | 2019 | 2050 | 0.45 | Why? |
Muscular Diseases | 1 | 2017 | 392 | 0.45 | Why? |
Cholesterol | 4 | 2019 | 660 | 0.44 | Why? |
Proprotein Convertase 9 | 5 | 2019 | 141 | 0.43 | Why? |
Cardiology | 3 | 2020 | 2873 | 0.41 | Why? |
Risk Reduction Behavior | 1 | 2017 | 946 | 0.41 | Why? |
Mitochondria | 1 | 2017 | 857 | 0.41 | Why? |
Apolipoproteins E | 3 | 2017 | 170 | 0.40 | Why? |
Natriuretic Peptide, Brain | 1 | 2017 | 1215 | 0.39 | Why? |
Hyperlipidemias | 4 | 2019 | 290 | 0.38 | Why? |
RNA, Viral | 4 | 2020 | 32276 | 0.36 | Why? |
Hydroxymethylglutaryl CoA Reductases | 2 | 2017 | 8 | 0.36 | Why? |
Diabetes Mellitus, Type 2 | 3 | 2018 | 6166 | 0.35 | Why? |
Subtilisins | 2 | 2017 | 29 | 0.35 | Why? |
Telomere | 2 | 2019 | 146 | 0.34 | Why? |
Atrial Fibrillation | 5 | 2021 | 2320 | 0.33 | Why? |
Brain Ischemia | 4 | 2021 | 2813 | 0.33 | Why? |
Fatty Acids | 2 | 2019 | 238 | 0.33 | Why? |
Endothelial Cells | 1 | 2017 | 2048 | 0.33 | Why? |
Rats, Sprague-Dawley | 3 | 2019 | 987 | 0.33 | Why? |
Blood Platelets | 1 | 2017 | 1704 | 0.31 | Why? |
Peptide Fragments | 1 | 2017 | 2075 | 0.31 | Why? |
Hemodynamics | 3 | 2019 | 1562 | 0.30 | Why? |
Serine Proteinase Inhibitors | 2 | 2019 | 341 | 0.29 | Why? |
Ezetimibe | 3 | 2019 | 50 | 0.29 | Why? |
Angiotensin Receptor Antagonists | 2 | 2019 | 3892 | 0.29 | Why? |
Magnetic Resonance Imaging, Cine | 2 | 2020 | 669 | 0.27 | Why? |
Cells, Cultured | 4 | 2019 | 5835 | 0.27 | Why? |
Mice, Knockout | 3 | 2018 | 1815 | 0.26 | Why? |
Angiotensin-Converting Enzyme Inhibitors | 2 | 2019 | 5277 | 0.26 | Why? |
Humans | 71 | 2021 | 930598 | 0.26 | Why? |
Dyspnea | 1 | 2017 | 3847 | 0.25 | Why? |
Mice, Inbred C57BL | 4 | 2018 | 5542 | 0.25 | Why? |
Secondary Prevention | 2 | 2019 | 762 | 0.25 | Why? |
Radiography, Thoracic | 1 | 2020 | 5486 | 0.25 | Why? |
Biomarkers | 14 | 2019 | 23361 | 0.24 | Why? |
Exercise | 2 | 2020 | 6771 | 0.24 | Why? |
Prospective Studies | 12 | 2020 | 43301 | 0.24 | Why? |
Pravastatin | 1 | 2001 | 10 | 0.23 | Why? |
Germany | 6 | 2019 | 9196 | 0.22 | Why? |
Osteoporosis, Postmenopausal | 1 | 2001 | 75 | 0.21 | Why? |
Heart Diseases | 1 | 2018 | 3503 | 0.21 | Why? |
Dicarboxylic Acids | 1 | 2019 | 12 | 0.20 | Why? |
Oxygen Consumption | 3 | 2020 | 711 | 0.20 | Why? |
Apolipoprotein B-100 | 1 | 2019 | 18 | 0.20 | Why? |
Cross-Over Studies | 2 | 2020 | 867 | 0.20 | Why? |
Lipoproteins, VLDL | 1 | 2019 | 8 | 0.20 | Why? |
Connective Tissue Growth Factor | 1 | 2019 | 8 | 0.20 | Why? |
rac1 GTP-Binding Protein | 1 | 2019 | 32 | 0.20 | Why? |
NADP Transhydrogenase, AB-Specific | 1 | 2018 | 1 | 0.20 | Why? |
Risk Factors | 17 | 2021 | 71621 | 0.20 | Why? |
Aorta | 3 | 2019 | 355 | 0.19 | Why? |
Mice, Inbred DBA | 1 | 2018 | 56 | 0.19 | Why? |
Male | 35 | 2021 | 367725 | 0.19 | Why? |
Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.19 | Why? |
Physical Conditioning, Human | 1 | 2019 | 57 | 0.19 | Why? |
Disease Management | 1 | 2017 | 6841 | 0.18 | Why? |
Neuropeptides | 1 | 2019 | 91 | 0.18 | Why? |
Echocardiography, Doppler, Color | 1 | 2019 | 114 | 0.18 | Why? |
Proto-Oncogene Proteins c-kit | 1 | 2018 | 59 | 0.18 | Why? |
Diet Therapy | 1 | 2019 | 66 | 0.18 | Why? |
Vasodilation | 2 | 2019 | 258 | 0.18 | Why? |
Animals, Newborn | 1 | 2019 | 350 | 0.18 | Why? |
Practice Guidelines as Topic | 3 | 2018 | 15421 | 0.18 | Why? |
Aminoimidazole Carboxamide | 1 | 2017 | 6 | 0.18 | Why? |
Life Style | 3 | 2019 | 2708 | 0.18 | Why? |
Cholesterol Ester Transfer Proteins | 1 | 2017 | 8 | 0.18 | Why? |
Organelle Biogenesis | 1 | 2017 | 15 | 0.18 | Why? |
Leukocyte Common Antigens | 1 | 2018 | 101 | 0.18 | Why? |
Apolipoproteins B | 1 | 2017 | 47 | 0.18 | Why? |
Fibronectins | 1 | 2018 | 92 | 0.18 | Why? |
Proprotein Convertases | 1 | 2017 | 28 | 0.18 | Why? |
Postmenopause | 1 | 2019 | 160 | 0.17 | Why? |
Alternative Splicing | 1 | 2018 | 82 | 0.17 | Why? |
Athletic Performance | 1 | 2020 | 208 | 0.17 | Why? |
Masks | 1 | 2020 | 8528 | 0.17 | Why? |
Genetic Pleiotropy | 1 | 2017 | 13 | 0.17 | Why? |
Mitochondrial Proteins | 1 | 2018 | 152 | 0.17 | Why? |
Electrocardiography, Ambulatory | 2 | 2018 | 204 | 0.17 | Why? |
Homozygote | 1 | 2018 | 230 | 0.17 | Why? |
Electrocardiography | 5 | 2021 | 3957 | 0.17 | Why? |
Monitoring, Physiologic | 2 | 2021 | 1956 | 0.17 | Why? |
Atrial Appendage | 1 | 2019 | 120 | 0.17 | Why? |
Treatment Outcome | 12 | 2019 | 51732 | 0.16 | Why? |
Ribonucleotides | 1 | 2017 | 96 | 0.16 | Why? |
Cardiomegaly | 1 | 2017 | 96 | 0.16 | Why? |
Echocardiography, Three-Dimensional | 1 | 2018 | 135 | 0.16 | Why? |
Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
Cardiopulmonary Bypass | 1 | 2018 | 158 | 0.16 | Why? |
Quantitative Trait Loci | 1 | 2018 | 340 | 0.16 | Why? |
Obesity | 3 | 2019 | 7388 | 0.16 | Why? |
Transforming Growth Factor beta | 1 | 2019 | 363 | 0.16 | Why? |
Animals | 11 | 2019 | 78931 | 0.16 | Why? |
Diet, High-Fat | 1 | 2017 | 161 | 0.16 | Why? |
Middle Aged | 26 | 2021 | 270681 | 0.16 | Why? |
Lipoprotein(a) | 1 | 2017 | 92 | 0.16 | Why? |
Gene Deletion | 1 | 2018 | 430 | 0.16 | Why? |
Triglycerides | 1 | 2019 | 478 | 0.15 | Why? |
Femoral Artery | 1 | 2018 | 213 | 0.15 | Why? |
Biological Availability | 1 | 2017 | 388 | 0.15 | Why? |
Blood Component Removal | 1 | 2018 | 175 | 0.15 | Why? |
Female | 31 | 2021 | 380317 | 0.15 | Why? |
Heart Rate | 2 | 2019 | 1527 | 0.15 | Why? |
Drug Utilization | 1 | 2021 | 619 | 0.15 | Why? |
Vascular Stiffness | 1 | 2019 | 264 | 0.15 | Why? |
Body Mass Index | 4 | 2019 | 4306 | 0.15 | Why? |
Lipoproteins, HDL | 1 | 2017 | 154 | 0.15 | Why? |
Drug Costs | 1 | 2019 | 313 | 0.15 | Why? |
Echocardiography, Transesophageal | 1 | 2019 | 447 | 0.15 | Why? |
Cataract | 1 | 2018 | 186 | 0.14 | Why? |
Diabetic Angiopathies | 1 | 2017 | 146 | 0.14 | Why? |
Cardiorespiratory Fitness | 1 | 2019 | 313 | 0.14 | Why? |
Time Factors | 11 | 2019 | 31397 | 0.14 | Why? |
Diabetes Mellitus | 1 | 2017 | 8207 | 0.14 | Why? |
Polypharmacy | 1 | 2017 | 347 | 0.14 | Why? |
Endothelium, Vascular | 3 | 2017 | 1751 | 0.14 | Why? |
Autonomic Denervation | 1 | 2013 | 2 | 0.14 | Why? |
NF-E2-Related Factor 2 | 1 | 2018 | 373 | 0.14 | Why? |
Cell Movement | 1 | 2018 | 695 | 0.14 | Why? |
Rats | 2 | 2019 | 2764 | 0.14 | Why? |
Homeostasis | 1 | 2018 | 582 | 0.14 | Why? |
Arginine | 1 | 2017 | 377 | 0.14 | Why? |
Sarcoidosis | 1 | 2018 | 271 | 0.14 | Why? |
Drug Substitution | 1 | 2017 | 385 | 0.14 | Why? |
Coronary Artery Disease | 2 | 2019 | 2570 | 0.14 | Why? |
Cardiotonic Agents | 1 | 2017 | 418 | 0.13 | Why? |
Expert Testimony | 1 | 2018 | 658 | 0.13 | Why? |
Adipose Tissue | 1 | 2019 | 612 | 0.13 | Why? |
Evidence-Based Medicine | 2 | 2017 | 3228 | 0.13 | Why? |
Glucose | 1 | 2018 | 573 | 0.13 | Why? |
Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
Phosphorylation | 1 | 2017 | 1060 | 0.13 | Why? |
Genetic Testing | 1 | 2017 | 395 | 0.13 | Why? |
Biological Evolution | 1 | 2019 | 641 | 0.13 | Why? |
Receptors, Immunologic | 1 | 2017 | 555 | 0.13 | Why? |
Chemical and Drug Induced Liver Injury | 1 | 2018 | 451 | 0.13 | Why? |
Genetic Variation | 2 | 2017 | 3919 | 0.13 | Why? |
Cognition Disorders | 1 | 2018 | 574 | 0.12 | Why? |
Phenotype | 3 | 2018 | 4037 | 0.12 | Why? |
Cattle | 1 | 2017 | 1336 | 0.12 | Why? |
Drug Therapy, Combination | 4 | 2019 | 7268 | 0.12 | Why? |
Lipids | 2 | 2017 | 1079 | 0.12 | Why? |
Databases, Factual | 2 | 2018 | 6248 | 0.12 | Why? |
Antigens, CD | 1 | 2017 | 984 | 0.12 | Why? |
Immunoglobulins | 1 | 2017 | 811 | 0.12 | Why? |
Healthy Lifestyle | 1 | 2017 | 447 | 0.12 | Why? |
Anti-Arrhythmia Agents | 2 | 2017 | 325 | 0.12 | Why? |
Mice, Transgenic | 1 | 2019 | 2739 | 0.12 | Why? |
Aged | 18 | 2021 | 215776 | 0.12 | Why? |
Disease Models, Animal | 3 | 2019 | 10998 | 0.11 | Why? |
Vaccines, Subunit | 1 | 2017 | 1088 | 0.11 | Why? |
Educational Status | 1 | 2017 | 1451 | 0.11 | Why? |
Kidney | 2 | 2017 | 3648 | 0.11 | Why? |
Impotence, Vasculogenic | 1 | 2010 | 3 | 0.11 | Why? |
Lung | 1 | 2020 | 31049 | 0.11 | Why? |
Societies, Medical | 2 | 2017 | 6907 | 0.11 | Why? |
Myocardial Infarction | 1 | 2007 | 3361 | 0.11 | Why? |
Cell Proliferation | 1 | 2018 | 1973 | 0.11 | Why? |
Drug Combinations | 2 | 2019 | 3852 | 0.11 | Why? |
Environment | 1 | 2017 | 769 | 0.10 | Why? |
Pandemics | 5 | 2021 | 389249 | 0.10 | Why? |
Heart | 1 | 2020 | 1791 | 0.10 | Why? |
Cerebral Hemorrhage | 1 | 2018 | 820 | 0.10 | Why? |
Fatal Outcome | 1 | 2020 | 3438 | 0.10 | Why? |
Benzazepines | 1 | 2010 | 49 | 0.10 | Why? |
RNA | 1 | 2018 | 1278 | 0.10 | Why? |
Penile Erection | 1 | 2010 | 58 | 0.10 | Why? |
Mice | 3 | 2019 | 21357 | 0.10 | Why? |
Penis | 1 | 2010 | 101 | 0.10 | Why? |
Self Care | 1 | 2017 | 918 | 0.10 | Why? |
Exercise Therapy | 1 | 2017 | 976 | 0.09 | Why? |
Antibodies, Monoclonal | 2 | 2019 | 8041 | 0.09 | Why? |
Feasibility Studies | 1 | 2018 | 3467 | 0.09 | Why? |
Down-Regulation | 3 | 2019 | 1416 | 0.09 | Why? |
Smoking Cessation | 1 | 2017 | 826 | 0.09 | Why? |
Chronic Disease | 3 | 2019 | 5139 | 0.09 | Why? |
Waist-Hip Ratio | 1 | 2007 | 50 | 0.09 | Why? |
Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.08 | Why? |
Recovery of Function | 1 | 2017 | 2461 | 0.08 | Why? |
Kidney Diseases | 1 | 2018 | 1434 | 0.08 | Why? |
Internal-External Control | 1 | 2007 | 65 | 0.08 | Why? |
Pilot Projects | 1 | 2018 | 5182 | 0.08 | Why? |
Inflammation Mediators | 1 | 2017 | 2654 | 0.08 | Why? |
Risk Assessment | 6 | 2019 | 25439 | 0.08 | Why? |
Cognitive Dysfunction | 1 | 2017 | 1389 | 0.08 | Why? |
Consensus | 2 | 2017 | 6345 | 0.08 | Why? |
Comorbidity | 4 | 2019 | 34796 | 0.07 | Why? |
Autoimmune Diseases | 1 | 2019 | 1996 | 0.07 | Why? |
Arrhythmias, Cardiac | 1 | 2019 | 2510 | 0.07 | Why? |
Prognosis | 6 | 2019 | 32490 | 0.07 | Why? |
Inflammation | 2 | 2018 | 13255 | 0.07 | Why? |
Risk | 1 | 2017 | 5288 | 0.07 | Why? |
Signal Transduction | 2 | 2019 | 7207 | 0.07 | Why? |
Blood Pressure | 2 | 2013 | 2198 | 0.07 | Why? |
Acute Coronary Syndrome | 1 | 2018 | 2107 | 0.07 | Why? |
Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
Electronic Health Records | 1 | 2017 | 3492 | 0.07 | Why? |
Cross-Sectional Studies | 4 | 2017 | 53120 | 0.07 | Why? |
Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.07 | Why? |
Hypertension | 2 | 2017 | 8895 | 0.06 | Why? |
Europe | 2 | 2017 | 12702 | 0.06 | Why? |
Stress, Psychological | 1 | 2007 | 10231 | 0.06 | Why? |
Aged, 80 and over | 5 | 2021 | 88759 | 0.06 | Why? |
Reproducibility of Results | 2 | 2017 | 11304 | 0.06 | Why? |
Antibodies, Monoclonal, Humanized | 3 | 2019 | 9335 | 0.06 | Why? |
Research Design | 1 | 2019 | 5830 | 0.06 | Why? |
Liver | 1 | 2017 | 4007 | 0.06 | Why? |
Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.06 | Why? |
Age Factors | 2 | 2017 | 21039 | 0.06 | Why? |
Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
Cell Line | 1 | 2017 | 12040 | 0.06 | Why? |
Adult | 7 | 2020 | 244371 | 0.05 | Why? |
Quality of Life | 2 | 2019 | 9820 | 0.05 | Why? |
Brain | 1 | 2017 | 5133 | 0.05 | Why? |
Vitamin D Deficiency | 1 | 2013 | 1782 | 0.05 | Why? |
Fibrillar Collagens | 1 | 2019 | 6 | 0.05 | Why? |
Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
Sitosterols | 1 | 2018 | 7 | 0.05 | Why? |
Heredity | 1 | 2018 | 37 | 0.05 | Why? |
Prevalence | 2 | 2019 | 25773 | 0.05 | Why? |
Depression | 2 | 2017 | 14116 | 0.05 | Why? |
Spliceosomes | 1 | 2018 | 15 | 0.05 | Why? |
Viroids | 1 | 2018 | 4 | 0.05 | Why? |
Paracrine Communication | 1 | 2019 | 73 | 0.05 | Why? |
Genetic Predisposition to Disease | 3 | 2018 | 4027 | 0.05 | Why? |
Brachial Artery | 1 | 2019 | 107 | 0.05 | Why? |
Introns | 1 | 2018 | 112 | 0.04 | Why? |
Pulse Wave Analysis | 1 | 2019 | 221 | 0.04 | Why? |
Arteriosclerosis | 1 | 1997 | 50 | 0.04 | Why? |
Tachycardia | 1 | 2019 | 239 | 0.04 | Why? |
Vitamin D | 1 | 2013 | 2904 | 0.04 | Why? |
Myocardial Contraction | 1 | 2019 | 123 | 0.04 | Why? |
Double-Blind Method | 2 | 2019 | 5988 | 0.04 | Why? |
RNA, Bacterial | 1 | 2018 | 116 | 0.04 | Why? |
Cell Count | 1 | 2018 | 228 | 0.04 | Why? |
Exons | 1 | 2018 | 158 | 0.04 | Why? |
Arterial Pressure | 1 | 2019 | 208 | 0.04 | Why? |
Pedigree | 1 | 2018 | 502 | 0.04 | Why? |
Markov Chains | 1 | 2019 | 502 | 0.04 | Why? |
Registries | 1 | 2017 | 12327 | 0.04 | Why? |
Cost Savings | 1 | 2019 | 296 | 0.04 | Why? |
Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
Tablets | 1 | 2017 | 219 | 0.04 | Why? |
Heart Conduction System | 1 | 2019 | 266 | 0.04 | Why? |
Quality-Adjusted Life Years | 1 | 2019 | 511 | 0.04 | Why? |
Models, Economic | 1 | 2019 | 316 | 0.04 | Why? |
Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
Endothelium | 1 | 2019 | 460 | 0.04 | Why? |
Models, Genetic | 1 | 2018 | 434 | 0.04 | Why? |
Clinical Trials, Phase III as Topic | 1 | 2019 | 782 | 0.04 | Why? |
Diuretics | 1 | 2017 | 326 | 0.04 | Why? |
Mendelian Randomization Analysis | 1 | 2017 | 317 | 0.04 | Why? |
Stroke | 1 | 2018 | 8839 | 0.04 | Why? |
Hypolipidemic Agents | 1 | 2017 | 208 | 0.04 | Why? |
Heart Valve Diseases | 1 | 2019 | 355 | 0.03 | Why? |
Cerebral Infarction | 1 | 1997 | 245 | 0.03 | Why? |
Nucleic Acid Conformation | 1 | 2018 | 621 | 0.03 | Why? |
Particle Size | 1 | 2019 | 1052 | 0.03 | Why? |
Epidemiologic Methods | 1 | 2017 | 392 | 0.03 | Why? |
Predictive Value of Tests | 2 | 2020 | 9537 | 0.03 | Why? |
Smoking | 1 | 2007 | 3358 | 0.03 | Why? |
Overweight | 1 | 2019 | 916 | 0.03 | Why? |
Antihypertensive Agents | 2 | 2017 | 1962 | 0.03 | Why? |
RNA, Long Noncoding | 1 | 2018 | 408 | 0.03 | Why? |
Reactive Oxygen Species | 1 | 2019 | 1136 | 0.03 | Why? |
Nervous System Diseases | 1 | 2011 | 4092 | 0.03 | Why? |
Drug Administration Schedule | 1 | 2019 | 2324 | 0.03 | Why? |
Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
Cholesterol, Dietary | 1 | 2010 | 8 | 0.03 | Why? |
Drug Resistance | 1 | 2013 | 395 | 0.03 | Why? |
Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.03 | Why? |
Superoxides | 1 | 2010 | 36 | 0.03 | Why? |
Myocardial Ischemia | 1 | 1997 | 781 | 0.03 | Why? |
Surveys and Questionnaires | 1 | 2017 | 43792 | 0.03 | Why? |
Nitric Oxide Synthase Type III | 1 | 2010 | 87 | 0.03 | Why? |
Heart Ventricles | 1 | 2019 | 1139 | 0.03 | Why? |
Clinical Trials as Topic | 2 | 2017 | 7330 | 0.02 | Why? |
Retrospective Studies | 2 | 2019 | 105322 | 0.02 | Why? |
Cost-Benefit Analysis | 1 | 2019 | 2259 | 0.02 | Why? |
Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
Child | 1 | 2018 | 70012 | 0.02 | Why? |
Follow-Up Studies | 2 | 2019 | 17020 | 0.02 | Why? |
Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
Collagen | 1 | 2010 | 222 | 0.02 | Why? |
Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
Vasodilator Agents | 1 | 2010 | 344 | 0.02 | Why? |
Enzyme Inhibitors | 1 | 2017 | 1881 | 0.02 | Why? |
Patient Compliance | 1 | 2015 | 1468 | 0.02 | Why? |
Cause of Death | 1 | 2019 | 4823 | 0.02 | Why? |
Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
Longitudinal Studies | 1 | 2019 | 9893 | 0.02 | Why? |
Acute Disease | 1 | 2015 | 6029 | 0.02 | Why? |
Serine Endopeptidases | 1 | 2018 | 4606 | 0.01 | Why? |
Patient Selection | 1 | 2017 | 4560 | 0.01 | Why? |
Survival Rate | 1 | 2017 | 9206 | 0.01 | Why? |
Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
Dose-Response Relationship, Drug | 1 | 2010 | 3776 | 0.01 | Why? |
Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
Length of Stay | 1 | 2015 | 11042 | 0.01 | Why? |
Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
Anticoagulants | 1 | 2015 | 9563 | 0.01 | Why? |
Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
United States | 1 | 2019 | 46150 | 0.01 | Why? |
Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
Adolescent | 1 | 2017 | 86841 | 0.01 | Why? |
Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |